PRCT
Procept Biorobotics Corp
NASDAQ: PRCT · HEALTHCARE · MEDICAL DEVICES
$24.04
+10.73% today
Updated 2026-04-30
Market cap
$1.24B
P/E ratio
—
P/S ratio
4.01x
EPS (TTM)
$-1.72
Dividend yield
—
52W range
$19 – $67
Volume
1.8M
Procept Biorobotics Corp (PRCT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-31.00%
Operating margin
-40.60%
ROE
-24.90%
ROA
-12.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $6.17M | $-41.98M | -30.56% | -705.95% | -680.42% |
| 2020 | $7.72M | $-53.02M | -16.26% | -619.44% | -687.04% |
| 2021 | $34.47M | $-59.85M | 46.02% | -157.12% | -173.62% |
| 2022 | $75.01M | $-87.15M | 49.44% | -107.61% | -116.18% |
| 2023 | $136.19M | $-105.90M | 52.17% | -80.16% | -77.76% |
| 2024 | $224.50M | $-91.41M | 61.07% | -43.04% | -40.72% |
| 2025 | $308.05M | $-95.57M | 63.70% | -33.71% | -31.02% |